findmyKOL

Sahil Bakshi, DO

Basic profile

Heart Hospital Baylor Plano

ORCIDNone on fileNPI
RegionPlano, TX · South CentralSpecialtyCardiovascular DiseaseFocusCardiology
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Sahil Bakshi is a Cardiology physician affiliated with Heart Hospital Baylor Plano. OpenAlex indexes 18 publications with 446 citations (h-index 5).

Overview

Scholarship

indexed output and impact (OpenAlex)
18publications

Distinct works indexed by OpenAlex.

446citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
15companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Industry payments

15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

15 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    85.6%
    Statin19.1%
    Atorvastatin Calcium46%Rosuvastatin Calcium31%Pravastatin Sodium13%Simvastatin9%Lovastatin1%
    Part D<11 patients
    Beta blocker15.7%
    Metoprolol Succinate37%Carvedilol35%Metoprolol Tartrate22%Atenolol3%Nebivolol Hcl2%Sotalol2%
    Part D<11 patients

    + 18 more classes in this area

  • Blood & clotting

    11.8%
    Factor Xa inhibitor7%
    Eliquis78%Xarelto22%
    Part D71 patients
    P2Y12 inhibitor3.5%
    Clopidogrel89%Brilinta12%
    Part D<11 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    2.1%
    Potassium supplement1.3%
    Potassium Chloride100%
    Part D29 patients
    Proton pump inhibitor0.6%
    Pantoprazole Sodium100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)22.3% facility · 77.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”